
Sartorius Stedim BioOutsource Increases Value for its Clients with Biopharmaceutical Platform Solution with UNIFI
Adds Structural Characterization of Novel Monoclonal Antibodies and Biosimilars by LC-MS to Testing Capabilities
Sartorius Stedim BioOutsource, a part of the Sartorius Stedim Biotech (SSB) Group since 2015, provides a comprehensive range of contract testing services for biologics, vaccines, and biosimilars throughout development and manufacture. Its goal is to provide customers with the most timely, accurate, and comprehensive data to support regulatory submissions.
Download this case study to learn how Sartorius Stedim BioOutsource integrated LC-MS technology with UNIFI to link mAb structural analysis to biological function and accelerate biosimilar development.
